ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of billions of therapeutic possibilities, ShapeTX is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer’s, Parkinson’s, and many more.
External link for Shape Therapeutics Inc.
219 Terry Ave N
Seattle, Washington 98109, US
Shape Therapeutics Inc. reposted this
RNA editing and gene therapy startup Shape Therapeutics Inc. is looking for a permanent CEO as Francois Vigneault has departed for new ventures. I spoke with interim CEO and CSO David Huss about Shape's partnerships, financing plans and pipeline updates this afternoon: #shapetherapeutics #rnaediting #genetherapy #biotech #biotechceo #seattlebiotech
We are pleased to welcome David Epstein and Todd Simpson to our board of directors. Both have proven track records in the life sciences industry and their experience and expertise will be invaluable in further solidifying our position as a leader in AI for genomic medicine. #Leadership #Innovation #AI #GenomicMedicine #Biotech https://lnkd.in/gEBfg6Aw
Shape's Head of AI Ron Hause had a great conversation with Benchling about implementing AI in Biotech https://lnkd.in/gt-FGWbM
Amazing work from the Shape scientific team! Achieving >90% Editing in Mouse and Non-Human Primate Brain with the RNAfix platform https://lnkd.in/gGYyH7wJ
ShapeTX is once again taking over Union Square for #jpm2024! Look out for our kiosk ads throughout the area and visit ShapeTX.com to learn more about our work in engineering programmable medicines!
Heading to the JP Morgan Healthcare Conference next week? Meet with us onsite to learn more about our work creating programmable medicines with AI and RNA! Reach out via our contact form to set up a meeting: https://bit.ly/47mT99A
Calling all JPM Healthcare Conference attendees - join our VP of Process and Product Development, Ken Prentice as he moderates a panel on next-generation gene therapy for GenScript's Biotech Global Forum on Jan 10 at 3:20 PM! Tickets available here: https://bit.ly/3S6yu4b
Our latest news update was an expansion of our partnership with Roche. In December, Roche added an additional target by utilizing our AI-powered RNAfix™ platform. What a great way to close out 2023! Read about this and other ShapeTX news via Fierce Biotech: https://bit.ly/3R1l4pw